Loading clinical trials...
Loading clinical trials...
Phase II Trial of Non-Invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders
Conditions
Interventions
MagStim
Sham Comparator
Locations
1
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Start Date
May 6, 2022
Primary Completion Date
April 25, 2025
Completion Date
December 1, 2026
Last Updated
June 3, 2025
NCT06872788
NCT03660098
NCT05289284
NCT05967078
NCT05345340
NCT03717376
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions